Evidence map›Paper›PMID 38709176›Full record

ArticleThe Journal of general physiology2024

Tail length and E525K dilated cardiomyopathy mutant alter human β-cardiac myosin super-relaxed state.

Sebastian Duno-Miranda, Shane R Nelson, David V Rasicci, Skylar M L Bodt, Joseph A Cirilo, Duha Vang, Sivaraj Sivaramakrishnan, Christopher M Yengo, David M Warshaw

Abstract read
In one paragraph

Article in The Journal of general physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A FRET assay to monitor different structural states of human β-cardiac myosin including the interacting-heads motif.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Sebastian Duno-MirandaDepartment of Molecular Physiology and Biophysics, Cardiovascular Research Institute, University of Vermont, Burlington, VT, USA.ORCID 0000-0002-2618-1335
Shane R NelsonDepartment of Molecular Physiology and Biophysics, Cardiovascular Research Institute, University of Vermont, Burlington, VT, USA.ORCID 0000-0002-3032-6314
David V RasicciDepartment of Cellular and Molecular Physiology, Penn State College of Medicine, Hershey, PA, USA.ORCID 0000-0003-3891-0694
Skylar M L BodtDepartment of Cellular and Molecular Physiology, Penn State College of Medicine, Hershey, PA, USA.ORCID 0000-0002-5794-6927
Joseph A CiriloDepartment of Cellular and Molecular Physiology, Penn State College of Medicine, Hershey, PA, USA.ORCID 0000-0003-2135-5831
Duha VangDepartment of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, MN, USA.ORCID 0000-0002-8990-8968
Sivaraj SivaramakrishnanDepartment of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, MN, USA.ORCID 0000-0002-9541-6994
Christopher M YengoDepartment of Cellular and Molecular Physiology, Penn State College of Medicine, Hershey, PA, USA.ORCID 0000-0003-3987-9019
David M WarshawDepartment of Molecular Physiology and Biophysics, Cardiovascular Research Institute, University of Vermont, Burlington, VT, USA.ORCID 0000-0002-0071-8798

Funding

Impact of dilated cardiomyopathy mutations on cardiac myosin structure and functionR01HL163585 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Sivaraj Sivaramakrishnan, David M Warshaw · 2023 to 2026
$3.0M
Research supplement to promote diversity in Heath-related researchR01HL150953 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SIVARAMAKRISHNAN, SIVARAJ, WARSHAW, DAVID M · 2020 to 2023
$2.4M
NHLBI NIH HHS R01 HL150953NHLBI NIH HHS R01 HL163585NIH HHS HL150953
6 · The paper itself

Abstract

Dilated cardiomyopathy (DCM) is a condition characterized by impaired cardiac function, due to myocardial hypo-contractility, and is associated with point mutations in β-cardiac myosin, the molecular motor that powers cardiac contraction. Myocardial function can be modulated through sequestration of myosin motors into an auto-inhibited "super-relaxed" state (SRX), which may be further stabilized by a structural state known as the "interacting heads motif" (IHM). Here, we sought to determine whether hypo-contractility of DCM myocardium results from reduced function of individual myosin molecules or from decreased myosin availability to interact with actin due to increased IHM/SRX stabilization. We used an established DCM myosin mutation, E525K, and characterized the biochemical and mechanical activity of wild-type and mutant human β-cardiac myosin constructs that differed in the length of their coiled-coil tail, which dictates their ability to form the IHM/SRX state. We found that short-tailed myosin constructs exhibited low IHM/SRX content, elevated actin-activated ATPase activity, and fast velocities in unloaded motility assays. Conversely, longer-tailed constructs exhibited higher IHM/SRX content and reduced actomyosin ATPase and velocity. Our modeling suggests that reduced velocities may be attributed to IHM/SRX-dependent sequestration of myosin heads. Interestingly, longer-tailed E525K mutants showed no apparent impact on velocity or actomyosin ATPase at low ionic strength but stabilized IHM/SRX state at higher ionic strength. Therefore, the hypo-contractility observed in DCM may be attributable to reduced myosin head availability caused by enhanced IHM/SRX stability in E525K mutants.

Indexed as

Cardiac MyosinsCardiomyopathy, DilatedVentricular MyosinsActinsAnimalsHumansMutationMyocardial ContractionMyosin Heavy ChainsActinsCardiac MyosinsMYH7 protein, humanMyosin Heavy ChainsVentricular Myosins

Identifiers

PMID38709176
PMCPMC11074782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.